chr13-40560133-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_002015.4(FOXO1):c.1358G>A(p.Ser453Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000353 in 1,614,170 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_002015.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOXO1 | NM_002015.4 | c.1358G>A | p.Ser453Asn | missense_variant | 2/3 | ENST00000379561.6 | NP_002006.2 | |
FOXO1 | XM_011535008.3 | c.815G>A | p.Ser272Asn | missense_variant | 2/3 | XP_011533310.1 | ||
FOXO1 | XM_011535010.3 | c.647G>A | p.Ser216Asn | missense_variant | 2/3 | XP_011533312.1 | ||
FOXO1 | XM_047430204.1 | c.647G>A | p.Ser216Asn | missense_variant | 2/3 | XP_047286160.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOXO1 | ENST00000379561.6 | c.1358G>A | p.Ser453Asn | missense_variant | 2/3 | 1 | NM_002015.4 | ENSP00000368880 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152158Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000716 AC: 18AN: 251284Hom.: 0 AF XY: 0.0000957 AC XY: 13AN XY: 135790
GnomAD4 exome AF: 0.0000356 AC: 52AN: 1461894Hom.: 0 Cov.: 32 AF XY: 0.0000509 AC XY: 37AN XY: 727248
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152276Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74472
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 15, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at